Cargando…

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease

Parkinson's disease is a common multisystem neurodegenerative disorder characterized by typical motor and non-motor symptoms. There is an urgent need for biomarkers for assessment of disease severity, complications and prognosis. In addition, biomarkers reporting the underlying pathophysiology...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prell, Tino, Witte, Otto W., Grosskreutz, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418014/ https://www.ncbi.nlm.nih.gov/pubmed/30906277 http://dx.doi.org/10.3389/fneur.2019.00195

Ejemplares similares

Ultrasonography of the Vagus Nerve in Parkinson's Disease
por: Fedtke, Nadin, et al.
Publicado: (2018)

Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease
por: Mendorf, Sarah, et al.
Publicado: (2020)

Impact of subthreshold depression on health-related quality of life in patients with Parkinson’s disease based on cognitive status
por: Schönenberg, Aline, et al.
Publicado: (2021)

Association between different coping styles and health-related quality of life in people with Parkinson’s disease: a cross-sectional study
por: Liebermann, Jenny Doris, et al.
Publicado: (2020)

Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
por: Prell, Tino, et al.
Publicado: (2020)

Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Gaur, Nayana, et al.
Publicado: (2021)

Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson’s disease: A cross-sectional study
por: Gruber, Maria Theresa, et al.
Publicado: (2020)

What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease?
por: Mendorf, Sarah, et al.
Publicado: (2020)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a “Global Cohort”
por: Steinbach, Robert, et al.
Publicado: (2018)

Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
por: Perner, Caroline, et al.
Publicado: (2019)

Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
por: Prell, Tino, et al.
Publicado: (2019)

Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis
por: Prell, Tino, et al.
Publicado: (2019)

Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
por: Prell, Tino, et al.
Publicado: (2020)

Current and Desired Quality of Life in People with Parkinson’s Disease: The Calman Gap Increases with Depression
por: Prell, Tino, et al.
Publicado: (2020)

Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS)
por: Prell, Tino, et al.
Publicado: (2019)

Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model
por: Steinbach, Robert, et al.
Publicado: (2020)

Deconstructing Apathy in Parkinson's Disease: Challenges in Isolating Core Components of Apathy From Depression, Anxiety, and Fatigue
por: Ineichen, Christian, et al.
Publicado: (2021)

Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials
por: Prell, Tino, et al.
Publicado: (2020)

Longitudinal analysis of the Non-Motor Symptoms Scale in Parkinson's Disease (NMSS): An exploratory network analysis approach
por: Heimrich, Konstantin G., et al.
Publicado: (2023)

Poor sleep quality is associated with fatigue and depression in early Parkinson's disease: A longitudinal study in the PALS cohort
por: Koh, Matthew Rui En, et al.
Publicado: (2022)

Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
por: Dieckmann, Nora, et al.
Publicado: (2022)

Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease
por: Feldmann, Francis, et al.
Publicado: (2020)

Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
por: Steinbach, Robert, et al.
Publicado: (2020)

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients
por: Richter, Daniel, et al.
Publicado: (2018)

Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging
por: Prell, Tino, et al.
Publicado: (2019)

Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?
por: Prell, Tino, et al.
Publicado: (2016)

Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients
por: Perner, Caroline, et al.
Publicado: (2018)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

Knowledge, Attitudes, Practices, and Burden During the COVID-19 Pandemic in People with Parkinson’s Disease in Germany
por: Zipprich, Hannah M., et al.
Publicado: (2020)

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
por: Sasikumar, Sanskriti, et al.
Publicado: (2020)

Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2019)

Parietal Perfusion Alterations in Parkinson's Disease Patients Without Dementia
por: Pelizzari, Laura, et al.
Publicado: (2020)

APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease
por: Tunold, Jon-Anders, et al.
Publicado: (2021)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Effects of a Ketogenic Diet on Symptoms, Biomarkers, Depression, and Anxiety in Parkinson’s Disease: A Case Study
por: Tidman, Melanie
Publicado: (2022)

Gastric dysmotility in Parkinson's disease is not caused by alterations of the gastric pacemaker cells
por: Heimrich, Konstantin G., et al.
Publicado: (2019)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis
por: Hartung, Viktor, et al.
Publicado: (2014)

Predicting the fatigue in Parkinson's disease using inertial sensor gait data and clinical characteristics
por: Wang, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2rk7b5huedfs99cju2atfa4map